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Abstract
Background: Elevated plasma lactate has been shown to correlate with mortality in patients
with septic shock. Heat stress prior to sepsis has resulted in reduction in acute lung injury
and mortality. We investigated whether heat stress resulted in decreased plasma lactate
concentration and protected the lung by decreasing the inflammatory response to sepsis.
Results: Plasma lactate concentration was elevated in septic rats without prior heat stress.
Lactic acid levels were significantly lower in heat-treated septic rats (P<0.05) and were not
significantly different when compared with control rats. Septic rats with or without heat
pretreatment had significantly higher myeloperoxidase activity in the lung than did control
groups. Heat pretreatment did not prevent neutrophil infiltration or inflammatory mediator
production in the lung.
Conclusion: Prior heat stress ameliorates lactic acidemia in rat sepsis. Heat stress did not
attenuate the pulmonary inflammatory process. The mechanism of heat-induced protection
from lactic acidemia in sepsis needs to be further explored.
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Introduction
Septic shock continues to have a high mortality rate in
spite of earlier recognition, newer antibiotics, and
improved supportive care [1]. Severe sepsis is associated
with organ dysfunction, hypoperfusion, and hypotension.
Clinically, hypoperfusion manifests as lactic acidosis, olig-
uria, or altered mental status. The arterial lactate is a reli-
able marker of tissue perfusion and correlates with survival
[2–6]. A lactate of 2.0 mmol/l or greater is considered
indicative of inadequate tissue perfusion [4].
Sepsis is characterized by the inflammatory response to
bacteria, which begins when endotoxin induces
macrophages and monocytes to produce cytokines such
as tumor necrosis factor (TNF)-a and interleukin (IL)-1b
[7]. TNF-a and IL-1b then promote the release of numer-Critical Care    Vol 4 No 1 Deshpande et al
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ous other mediators, such as IL-6, IL-8, eicosanoids, and
macrophage inflammatory protein (MIP)-2 [8]. Acute lung
injury/acute respiratory distress syndrome (ARDS) is one
of the most common consequences of sepsis [9,10]. Neu-
trophil migration and sequestration within the lung is a his-
tologic hallmark of ARDS [11].
Heat stress response is an evolutionarily highly conserved
response, which is characterized by the production of heat
shock proteins [12,13]. These proteins are proposed to
have a protective role by taking part in the cellular repair
mechanism, by degradation of proteins beyond repair, and
by altering inflammatory cellular functions [12,13]. Heat
stress administered before sepsis has resulted in cardiac
protection, reduction in sepsis-induced acute lung injury,
and decreased mortality in animals [14–17]. The mecha-
nism of cardiopulmonary protection by heat in sepsis is
unknown but may be related to a decrease in proinflamma-
tory cytokine production.
The objectives of this study were to determine whether
heat stress resulted in decreased plasma lactate concen-
tration and protected the lung by decreasing the inflamma-
tory response to sepsis. Our hypotheses were that heat
exposure prior to sepsis results in attenuation of lactic
acidemia and that heat-exposed rats have less sepsis-
induced lung injury from suppression of inflammatory
response. We showed that heat stress ameliorates lactic
acidemia in rat sepsis but does not attenuate the pul-
monary inflammatory process.
Materials and methods
This study was approved by the Animal Investigation Com-
mittee at Wayne State University and performed in accor-
dance with US National Institutes of Health guidelines for
the use of animals in research. Thirty-two male
Sprague–Dawley rats (Charles Rivers Laboratories, Wilm-
ington, MA, USA) weighing 250–350 g, were assigned to
one of four groups: (1) heated with cecal ligation and per-
foration (CLP; n=10); (2) no heat and CLP (n=10); (3)
heat and sham CLP (n=6); and (4) no heat and sham
CLP (n=6).
Day 1
Rats were anesthetized with ketamine (60 mg/kg) and
xylazine (5 mg/kg). A rectal probe was placed to monitor
temperature.
Heat stress groups
Rats were placed in a small heating chamber, which was
previously warmed to 42°C. After 40–45 min, the rats’
temperatures reached 41°C, at which time the rats were
removed from the chamber and allowed to cool passively.
The temperature remained above 41°C for 10–15 min.
Rats were then returned to their cages and allowed free
access to food and water.
Normothermia groups
Rats were placed at room temperature for 45 min in the
same chamber that was previously used to heat the rats.
Rats were then returned to their cages and allowed free
access to food and water.
Day 2
All rats were again anesthetized with ketamine and xylazine.
Cecal ligation and perforation (groups 1 and 2)
CLP was performed as previously described [18]. Briefly,
a 2-cm midline incision was made and the cecum was iso-
lated. Stool was milked back from the ascending colon
into the cecum. The cecum was ligated just inferior to the
ileocecal valve to maintain the continuity between ileum
and colon. The antimesenteric surface was punctured
twice using an 18-gauge needle. The cecum was returned
to the abdomen and the abdomen was closed in two
layers. Rats were then given 0.9% saline (5 ml/kg body
weight) by intraperitoneal injection, and 0.1 ml buprenor-
phine subcutaneously.
Sham cecal ligation and perforation (groups 3 and 4)
A 2-cm midline incision was made and cecum was isolated.
It was returned to the abdomen without ligation or perfora-
tion. The abdomen was closed in two layers. Rats were then
given 0.9% saline (5 ml/kg body weight) by intraperitoneal
injection, and 0.1 ml buprenorphine subcutaneously.
Day 3
Arterial blood was obtained for blood gas, lactate and
determination of cytokines. The rats were then killed and
their cecums were inspected for evidence of ischemia.
The pulmonary artery was cannulated, abdominal aorta
was transected, and cold phosphate-buffered saline was
infused until the wash fluid from the severed aorta was
clear. The trachea was then cannulated and the lungs
were lavaged with 50 ml warmed phosphate-buffered
saline (37°C). The lavage fluid was then centrifuged and
the supernatant was saved at –70°C until further analysis.
Tumor necrosis factor-a a, interleukin-1b b, and macrophage
inflammatory protein-2 assays
All assays were performed using commercially available
kits (Biosource International, Camarillo, CA, USA). Previ-
ously coated microtiter plates containing the primary anti-
bodies specific for rat TNF-a, IL-1b, and MIP-2 were used.
After the addition of standard concentrations of the
respective cytokine and unknown samples of plasma or
lavage fluid, secondary cytokine specific antibodies were
placed into these wells. After removing excess antibody,
streptavidin–peroxidase was added, which binds to the
secondary biotinylated antibody. After washing the plate, a
substrate solution was added, which binds to strepta-
vidin–peroxidase to produce a color. The intensity of this
color is proportional to the TNF-a, IL-1b, or MIP-2 concen-47
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trations, respectively. The sensitivities of these assays are
less than 4 pg/ml, less than 20 pg/ml and less than 1
pg/ml for TNF-a, IL-1b, and MIP-2, respectively.
Myeloperoxidase assays
Myeloperoxidase activity was determined in the lung
tissue as previously described [19]. Lung tissue was
homogenized and suspended in a potassium phosphate
(50 mmol/l) buffer solution (reagent 1). It was cen-
trifuged at 40000× g for 30 min. The pellet was resus-
pended in hexadecyltrimethyl–amonium bromide buffer
(reagent 2). The tube contents were then sonicated with
an ultrasonic dismembrator for 10 s at 40% power, and
three cycles of freezing and thawing were performed,
after which the sonication was repeated. The tubes were
centrifuged again for 30 min. Supernatant (100 ml) was
added to reagent 1 with 0.167 mg/ml of O-dianisidine
dihydrochloride (Sigma Chemical, St Louis, Missouri,
USA) and 0.0005% hydrogen peroxide. Myeloperoxi-
dase activity in each sample (in triplicate) was deter-
mined by measuring the change in absorbency per
minute at 460 nm using a spectrophotometer (Shimadzu,
Wood Dale, Illinois, USA) capable of performing a kinetic
scan over 120 s. The protein content in 100 ml of sample
supernatant was determined (bicinchoninic acid kit
Sigma). Myeloperoxidase activity was expressed as
change in optical density/min/g/l protein.
6-Keto-prostaglandin F1a a and thromboxane B2 assays
Alveolar lavage fluid was analyzed for 6-keto-prostaglandin
F1a and thromboxane B2 using commercially available
enzyme immunoassay systems (Biotrak, Amersham Inter-
national plc, Buckinghamshire, UK). Peroxidase labeled
thromboxane B2 and 6-keto-prostaglandin F1a competes
with the thromboxane B2 and 6-keto-prostaglandin F1a in
the unknown sample for a limited number of binding sites
on the respective specific antibody. Tetramethyl benzidine
with hydrogen peroxide single pot substrate was added,
and after 15 min the reaction was stopped with sulfuric
acid. The optical density was determined at 450 nm using
a microtiter plate photometer. Concentrations of throm-
boxane B2 and 6-keto-prostaglandin F1a were determined
in lavage fluid samples from a standard curve. The sensi-
tivities of the thromboxane B2 and 6-keto-prostaglandin
F1a assays are 3.6 and 3.0 pg/ml, respectively.
Statistics
All variables were analyzed using a one-way analysis of vari-
ance with post hoc analysis using a Student Neuman–Keuhl
test when appropriate. Values are expressed as mean ±
standard error of the mean.
Results
Survival
Among rats with CLP, two rats in the heated group and
one rat in the unheated group died before sample collec-
tion. All rats receiving a sham operation survived regard-
less of administration of heat.
Cecum
Rats with CLP had ischemia of the cecum. The cecums of
sham rats appeared normal.
Plasma lactate
Plasma lactate concentration was significantly elevated in
rats with CLP without prior heat treatment (group 2;
P<0.05; Fig. 1). Pretreatment with heat resulted in pre-
vention of lactic acidemia in septic rats (group 1). Plasma
lactate concentrations in group 1 were similar to those in
control rats (groups 3 and 4).
Arterial blood gases
There was no difference in pH, partial carbon dioxide or
oxygen tensions, or alveolar–arterial oxygen gradient on
room air among the four groups (Table 1). When only the
rats with CLP were compared (groups 1 and 2), the alveo-
lar–arterial oxygen gradient was significantly lower in rats
receiving heat pretreatment (P<0.03; see Table 1).
Pulmonary myeloperoxidase activity
Pulmonary myeloperoxidase activity, an indicator of neu-
trophil aggregation, was significantly elevated in rats with
cecal ligation and perforation. Heat pretreatment did not
prevent the increase in myeloperoxidase activity in septic
rats (Fig. 2).
Figure 1
Plasma lactate concentrations. *P £ 0.05, versus all other groups. CLP,
cecal ligation and perforation.Cytokines and eicosanoids in plasma and lung lavage
TNF-a, IL-1b, and MIP-2 were not detected in the plasma.
Lavage fluid of the rats that had CLP contained TNF-a and
MIP-2 but no IL-1b. Pretreatment of the rats with heat did
not influence the production of these mediators.
Eicosanoids were present in the lavage but concentra-
tions did not differ among the groups (Table 2).
Discussion
In severe sepsis, lactic acidemia results from many different
mechanisms, such as supply dependency of oxygen utiliza-
tion favoring anaerobic metabolism [3], poor organ perfusion
[4], or metabolic consequences of reduced activity of pyru-
vate dehydrogenase in mitochondria [20]. In the present rat
model of endotoxemia, hyperlactatemia could have resulted
from shock, metabolic dysfunction, sepsis-induced liver
damage, and/or ARDS. Heat stress caused attenuation of an
increase in serum lactate in rats with CLP. The mechanism of
prevention of lactic acidemia by heat stress in sepsis is
unclear, but it may be related to decreased lactate produc-
tion or increased lactate clearance. Decreased lactate pro-
duction could be a result of either increased oxygen delivery
or improved mitochondrial oxygen utilization. A lower lactic
acid level in the heat-stressed septic rats could also reflect
improved organ perfusion, and therefore increased lactate
clearance and utilization.
Previous studies [14] have demonstrated that heat stress
protects against pulmonary injury in sepsis. Studies
[16,17] show that pretreatment of septic animals with heat
resulted in decreased endothelial damage and less pul-
monary edema than septic animals without prior exposure
to heat. Proposed mechanisms include the downregula-
tion of the inflammatory response, and attenuation of
TNF-a and IL-1b production, thus reducing acute lung
injury [14,15,21]. In the present study, septic rats had
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Figure 2
Pulmonary myeloperoxidase activity. *P £ 0.05, versus sham rats.
MPO, myeloperoxidase; CLP, cecal ligation and perforation.
Table 1
Blood gas values for various groups
Groups pH PaO2 (mmHg) PaCO2 (mmHg) A–aDO2 (mmHg)
Heat, CLP 7.34 ± 0.01 71 ± 5 53 ± 1 10 ± 3
No heat, CLP 7.37 ± 0.01 61 ± 5 53 ± 4 20 ± 2*
Heat alone 7.32 ± 0.03 70 ± 5 56 ± 3 6 ± 2
Control 7.34 ± 0.01 61 ± 6 55 ± 3 16 ± 6
Values are expressed as mean ± standard error of the mean. *P < 0.03 compared with the heat, cecal ligation and perforation (CLP) group.
A–aDO2, alveolar–arterial oxygen difference; PaCO2, arterial carbon dioxide tension; PaO2, arterial oxygen tension.
Table 2
Eicosanoid concentrations in the lavage fluid
Groups
Eicosanoids  Heat, CLP No heat, CLP Heat alone Control
TXB2 (pg/ml) 777 ± 281 627 ± 160 559 ± 161 595 ± 174
PGF2a (pg/ml) 680 ± 208 677 ± 182  334 ± 59  415 ± 65
Values are expressed as mean ± standard error of the mean. CLP, cecal ligation and perforation; PG, prostaglandin; TX, thromboxane.inflammation and acute lung injury as shown by sequestra-
tion of neutrophils in the lung indicated by pulmonary
myeloperoxidase activity. The myeloperoxidase activity in
the lungs was similar in septic rats with or without prior
heat stress. Attenuation of increase in lactic acid in the
heated, septic group does not appear to be related to
decreased pulmonary inflammation by heat stress.
Pulmonary protection from heat stress may depend on
duration of temperature exposure and peak body tempera-
ture reached. We have previously shown [22,23] that alve-
olar macrophages, and lung and spleen cells produced
heat shock protein when rats were heated to 41°C for
10–15 min according to the protocol utilized in the
present study. In cell culture studies, the inflammatory
mediator production in response to lipopolysaccharide
exposure has been shown to vary depending on the
degree and duration of heat stress [24,25]. Longer
periods of heat exposure or higher temperatures than
used in the present study might be more effective in atten-
uation of the pulmonary inflammatory response in sepsis.
In conclusion, we observed that heat stress ameliorated
lactic acidemia in a rat model of sepsis, possibly by pre-
serving the organ perfusion, improving oxygen delivery or
preventing cellular dysfunction. We were unable to
demonstrate attenuation of acute lung injury by heat stress
in endotoxemia. Further studies are required to determine
the optimal heat stress conditions for cardiopulmonary
protection of endotoxemic rats and regulation of the
inflammatory response.
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